Ummm Mylan........, page-3

This may have been posted before? apologies if it has?

It would appear that they are not to be trusted!


http://blogs.barrons.com/stockstowa...an-when-its-complicated-is-an-understatement/

Mylan: When ‘It’s Complicated’ is an Understatement
By Ben Levisohn

Last week, Mylan (MYL) CEO Heather Bresch blamed “the system” for the rise in EpiPen prices. Today, Wells Fargo’s David Maris and team dig into Mylan’s EpiPen4Schools.com program and finds that some of the complications may be by design. He explains:

AP​

We decided to research Mylan’s school giveaway program, EpiPen4Schools.com. When one goes to the EpiPen4Schools.com webpage, one can see on the banner, that at the top of the page, Mylan’s logo is displayed, but so is another company’s logo, BioRidge Pharma…
ased on our review, we were unable to find BioRidge Pharma listed as a pharmaceutical company among sources like IMS. However, BioRidge Pharma appears from its own website not to be a pharmaceutical company, but a logistics company, and on its webpage it states that it provides pharmaceutical and biotech manufacturers with logistics services, cost management, inventory management, and storage and tracking. Based on our review, we are uncertain whether BioRidge Pharma has any customers other than Mylan or whether Mylan represents the vast majority of BioRidge Pharma’s efforts. According to the EpiPen4Schools.com website, BioRidge Pharma is located at 200 Park Avenue, Suite 300, Florham Park, New Jersey. Interestingly, our investigation revealed that there is another business with the same exact address. It appears that a contract distributor named Asembia also operates at the same location. We tried repeatedly to reach BioRidge Pharma but were unable to discuss the company with management. We were also unable to find any mention of BioRidge or Asembia in Mylan’s most recent SEC filings…
…While this may simply be a case of a confusing distribution channel, we would like to better understand one of the activities Mylan has mentioned as part of its efforts to expand access through the years. Mylan has stated it has “provided” more than 700,000 EpiPens to schools – we do not know if this is for free, and whether this has been tax deductible for Mylan, and if so, was this done at cost or another potentially higher price.